Brain Cancer

Resectioning method impacts prognosis, survival rates

Published in Cancer Weekly, May 10th, 2005

Malignant gliomas, the most common neoplasm in the central nervous system, have a poor prognosis despite the frequent use of a therapeutic combination of surgery, radiotherapy and chemotherapy.

Complete surgical removal of these tumors is not possible due to their locally invasive nature within the brain. However, maximal cytoreductive surgery, aimed at removing at least contrast-enhancing tumor seen on magnetic resonance imaging (MRI), is generally considered beneficial. Unfortunately, complete resection of contrast-enhancing regions is only achieved in a small percentage of patients due, in part, to the difficulty of detecting contrast-enhancing tumor margins...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-05-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry